Clinical Trials Browser

Adenocarcinoma of the Pancreas × paricalcitol × Clear all

NCT02030860 2025-07-25

A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

Phase 1 Completed

Gastrointestinal

Adenocarcinoma of the Pancreas